Key result
C-terminally biotinylated filaggrin epitope core peptides were specifically recognized by autoantibodies from rheumatoid arthritis patients, whereas N-terminally biotinylated core peptides showed no binding.
Case-Control (n=48)
The position of biotinylation on filaggrin epitope peptides significantly affects autoantibody recognition in rheumatoid arthritis, which is critical for designing accurate diagnostic assays.
Biotin position may affect RA autoantibody assay sensitivity; leaves open clinical validation before diagnostic use.
Here, we report on the synthesis, conformational analysis, and autoantibody binding properties of new sets of rheumatoid arthritis (RA) specific biotin-peptide conjugates derived from filaggrin epitope peptides. The biotin with or without a linker was attached to the Cit or Arg containing epitope core ((311)TXGRS(315)) or epitope region ((306)SHQESTXGXSXGRSGRSGS(324)) peptide (where X = Cit), through an amide bond at the N- or C-terminal of the epitopes. Antibody binding was detected by indirect enzyme-linked immunosorbent assay (ELISA) using sera from RA, Systemic lupus erythematosus (SLE) patients, as well as healthy individuals, and the secondary structure of conjugates was investigated by electronic circular dichroism (ECD). We found that autoantibodies from RA patients recognize specifically both filaggrin epitope region ((306)SHQESTXGXSXGRSGRSGS(324)) and short epitope core ((311)TXGRS(315)) peptides. Our data also indicate that the positioning of the biotin label within a peptide sequence can markedly influence the antibody binding, but the length of the linker incorporated has essentially no effect on the recognition. ECD experiments demonstrate that the Arg/Cit change does not influence the solution conformation of the peptide conjugates. However, the presence and position of the biotin moiety has a pronounced effect on the conformation of the 5-mer epitope core peptides, while it does not alter the secondary structure of the 19-mer epitope region peptides.
No takes yet. Share an insight, caveat, or question.
Babos et al. (2013) conducted a case-control in Rheumatoid arthritis (n=48). C-terminal biotinylation of filaggrin epitope peptides vs. N-terminal biotinylation was evaluated on Autoantibody recognition (OD ratio) by indirect ELISA. C-terminally biotinylated filaggrin epitope core peptides were specifically recognized by autoantibodies from rheumatoid arthritis patients, whereas N-terminally biotinylated core peptides showed no binding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: